Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-037411
Filing Date
2022-12-02
Accepted
2022-12-02 16:15:17
Documents
2
Period of Report
2022-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1573
2 EX-24 DOCUMENT attachment1.htm EX-24 3923
  Complete submission text file 0000899243-22-037411.txt   6918
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATAI LIFE SCIENCES N.V. WALLSTRASSE 16 BERLIN 2M 10179
Business Address
Kirpekar Sahil (Reporting) CIK: 0001951712 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40493 | Film No.: 221442109